BioSpace News Archive

Press Releases

Defence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies

April 8, 2025
·
4 min read
Press Releases

City of Hope Study Demonstrates Proof of Concept for Targeted New Approach to Treat Pancreatic Cancer

April 8, 2025
·
5 min read
Press Releases

Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia

April 8, 2025
·
7 min read
Press Releases

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer1

April 8, 2025
·
19 min read
Press Releases

AbCellera to Participate at Upcoming Investor Conferences in May and June

April 8, 2025
·
1 min read
Press Releases

Amneal to Report First Quarter 2025 Results on May 2, 2025

April 8, 2025
·
1 min read
Press Releases

Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update

April 8, 2025
·
15 min read
Press Releases

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

April 8, 2025
·
4 min read
Press Releases

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs

April 8, 2025
·
5 min read
Press Releases

argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improved Quality of Life Measures for Patients Living with gMG and CIDP

April 8, 2025
·
15 min read